Endocrine Society’s Journal of the Endocrine Society receives first Impact Factor score

FHS
July 3, 2023
3:56 pm

The Endocrine Society’s Journal of the Endocrine Society (JES) received its first Impact Factor score in 2022, while the Society’s other journals maintained high rankings on the prestigious measure of scholarly publishing.

Sarepta’s Duchenne gene therapy fails to meet primary endpoint in pivotal trial

Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large

October 30, 2023

Opinion | Hepatitis C Vaccine Is Essential for Expediting Elimination

Pelosi is a scientific manager and researcher. Perkins is a senior advisor in governance. Remak is a patient advocate. Seid is a vaccine program lead.

July 14, 2023

East Asians under-represented in biopharma leadership

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. At the

January 8, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.